Cookie Notice
By continuing to use this website, you consent to our use of cookies and the other terms of our Privacy Policy.
For more information, please visit our Privacy Policy.
Lauren was diagnosed with CF during her childhood. She recently accepted a job where she works from home full-time. With classes and her new job, Lauren is still getting used to her new routine. She is open to exploring treatment options.
Medical history
Current CF care plan
Current lifestyle
Not an actual patient. Patient symptoms will vary; individual evaluation should be done to
determine best course of therapy.Michael has been managing his CF independently for over 20 years and was recently promoted at work. His new job has opened an exciting new chapter for him but comes with
additional responsibilities. He is open to exploring treatment options.Medical history
Current CF care plan
Current lifestyle
Not an actual patient. Patient symptoms will vary; individual evaluation should be
done to determine best course of therapy.Simon was diagnosed with CF at birth. He is 20 years old and recently started a part-time job while attending college full-time. He also recently moved out of his parents' home and is managing his CF on his own for the first time. He is open to exploring treatment options.
Medical history
Current CF care plan
Current lifestyle
Not an actual patient. Patient symptoms will vary; individual evaluation should be done to
determine best course of therapy.Diagnosed with CF from childhood and has previously
been fairly adherent to his CF care plan. After moving into his fraternity house, he became busier with school and social events. He is interested in exploring other treatment options.Medical history
Current CF care plan
Current lifestyle
PERT=pancreatic enzyme replacement therapy.
Not an actual patient. Patient symptoms will vary; individual evaluation should be
done to determine best course of therapy.BRONCHITOL can cause bronchospasm, which can be severe in susceptible patients. Because of the risk of bronchospasm, prior to prescribing BRONCHITOL, patients must pass the BRONCHITOL Tolerance Test (BTT). The BTT must be administered under the supervision of a healthcare practitioner who can treat severe bronchospasm.
Please see Full Prescribing Information.
Meghan has effectively managed her CF throughout her life. Recently, she has had less time to manage her CF due to her children's increasingly busy schedules. She is exploring other treatment options that may fit her schedule.
Medical history
Current CF care plan
Current lifestyle
Not an actual patient. Patient symptoms will vary; individual evaluation should be done to
determine best course of therapy.Learn more about dosing and administration
BRONCHITOL is not intended to be used as a rescue medication. Inhaler and blister pack are not actual size and are for representation only. Use an inhaled bronchodilator 5–15 minutes before taking BRONCHITOL.
BRONCHITOL is contraindicated in patients with hypersensitivity to mannitol or to any of the capsule components. BRONCHITOL is contraindicated in patients who fail to pass the BRONCHITOL Tolerance Test (BTT).
BRONCHITOL can cause bronchospasm, which can be severe in susceptible patients. Because of the risk of bronchospasm, prior to prescribing BRONCHITOL, patients must pass the BRONCHITOL Tolerance Test (BTT). The BTT must be administered under the supervision of a healthcare practitioner who can treat severe bronchospasm.
Patients who pass the BRONCHITOL tolerance test (BTT) may experience bronchospasm with add-on maintenance therapy with BRONCHITOL. Patients should premedicate with an inhaled short-acting bronchodilator prior to each administration of BRONCHITOL. If bronchospasm occurs, immediately discontinue BRONCHITOL and treat bronchospasm with an inhaled short-acting bronchodilator.
Hemoptysis can occur with BRONCHITOL use. Monitor patients with history of episodes of hemoptysis. If hemoptysis occurs, discontinue use of BRONCHITOL.
Most common adverse reactions (≥3%) include cough, hemoptysis, oropharyngeal pain, vomiting, bacteria sputum identified, pyrexia, and arthralgia.
BRONCHITOL® (mannitol) inhalation powder is a sugar alcohol indicated as add-on maintenance therapy to improve pulmonary function in adult patients 18 years of age and older with cystic fibrosis. Use BRONCHITOL only in adults who have passed the BRONCHITOL Tolerance Test.
Open
Close